256 related articles for article (PubMed ID: 16679755)
21. The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
Herder GJ; Golding RP; Hoekstra OS; Comans EF; Teule GJ; Postmus PE; Smit EF
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1231-6. PubMed ID: 15175835
[TBL] [Abstract][Full Text] [Related]
22. [Lung scintigraphy with technetium 99m depreotide in the assessment of solitary pulmonary nodules].
Rebollo AC; Jiménez-Hoyuela JM; Martínez del Valle MD; Fernández Aguirre C; Soria C; Velasco JL
Arch Bronconeumol; 2004 Nov; 40(11):534-6. PubMed ID: 15530345
[TBL] [Abstract][Full Text] [Related]
23. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy.
Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST
Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699
[TBL] [Abstract][Full Text] [Related]
24. 99mTc-depreotide scintigraphy versus 18F-FDG-PET in the diagnosis of radioiodine-negative thyroid cancer.
Rodrigues M; Li S; Gabriel M; Heute D; Greifeneder M; Virgolini I
J Clin Endocrinol Metab; 2006 Oct; 91(10):3997-4000. PubMed ID: 16895961
[TBL] [Abstract][Full Text] [Related]
25. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
Goldsmith SJ; Kostakoglu L
Semin Ultrasound CT MR; 2000 Apr; 21(2):129-38. PubMed ID: 10776885
[TBL] [Abstract][Full Text] [Related]
26. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
[TBL] [Abstract][Full Text] [Related]
28. 99mTc-tetrofosmin SPECT in solitary pulmonary nodule evaluation.
Spanu A; Schillaci O; Pirina P; Arru A; Madeddu G; Chessa F; Marongiu P; Solinas ME; Madeddu G
Oncol Rep; 2006 Oct; 16(4):763-9. PubMed ID: 16969491
[TBL] [Abstract][Full Text] [Related]
29. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules.
Chen S; Harmon S; Perk T; Li X; Chen M; Li Y; Jeraj R
Cancer Imaging; 2019 Aug; 19(1):56. PubMed ID: 31420006
[TBL] [Abstract][Full Text] [Related]
30. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules.
Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K;
J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626
[TBL] [Abstract][Full Text] [Related]
31. Role of scintigraphy with technetium-99m depreotide in the diagnosis and management of patients with suspected lung cancer.
Axelsson R; Herlin G; Bååth M; Aspelin P; Kölbeck KG
Acta Radiol; 2008 Apr; 49(3):295-302. PubMed ID: 18365818
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
Bar-Shalom R; Kagna O; Israel O; Guralnik L
Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
[TBL] [Abstract][Full Text] [Related]
33. Solitary pulmonary nodule evaluation in regions endemic for infectious diseases: Do regional variations impact the effectiveness of fluorodeoxyglucose positron emission tomography/computed tomography.
Purandare NC; Pramesh CS; Agarwal JP; Agrawal A; Shah S; Prabhash K; Karimundackal G; Jiwnani S; Tandon S; Rangarajan V
Indian J Cancer; 2017; 54(1):271-275. PubMed ID: 29199704
[TBL] [Abstract][Full Text] [Related]
34. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT.
Yi CA; Lee KS; Kim BT; Choi JY; Kwon OJ; Kim H; Shim YM; Chung MJ
J Nucl Med; 2006 Mar; 47(3):443-50. PubMed ID: 16513614
[TBL] [Abstract][Full Text] [Related]
35. The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.
Spadafora M; Evangelista L; Fiordoro S; Porcaro F; Sicignano M; Mansi L
Curr Radiopharm; 2020; 13(3):243-248. PubMed ID: 32186274
[TBL] [Abstract][Full Text] [Related]
36. Nuclear medicine imaging of lung cancer.
Goldsmith SJ; Kostakoglu L
Radiol Clin North Am; 2000 May; 38(3):511-24. PubMed ID: 10855258
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
38. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
39. [Technetium99 labelled synthetic somatostatin analogue (depreotide) in the diagnosis of peripheral solitary pulmonary nodules].
Chciałowski A; Dziuk E; From S; Płusa T; Lubiński W; Pietrzykowski J; Zabicka M; Hussain N
Pol Arch Med Wewn; 2004 Sep; 112(3):1031-8. PubMed ID: 15727084
[TBL] [Abstract][Full Text] [Related]
40. The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.
Macdonald K; Searle J; Lyburn I
Clin Radiol; 2011 Mar; 66(3):244-50. PubMed ID: 21295203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]